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BIBR1532 is a highly specific telomerase inhibitor,
although the molecular basis for inhibition is un-
known. Here we present the crystal structure of
BIBR1532 bound to Tribolium castaneum catalytic
subunit of telomerase (tcTERT). BIBR1532 binds to
a conserved hydrophobic pocket (FVYL motif) on
the outer surface of the thumb domain. The FVYL
motif is near TRBD residues that bind the activation
domain (CR4/5) of hTER. RNA binding assays show
that the human TERT (hTERT) thumb domain binds
the P6.1 stem loop of CR4/5 in vitro. hTERT muta-
tions of the FVYL pocket alter wild-type CR4/5 bind-
ing and cause telomere attrition in cells. Furthermore,
the hTERT FVYL mutations V1025F, N1028H, and
V1090M are implicated in dyskeratosis congenita
and aplastic anemia, further supporting the biolog-
ical and clinical relevance of this novel motif. We pro-
pose that CR4/5 contacts with the telomerase thumb
domain contribute to telomerase ribonucleoprotein
assembly and promote enzymatic activity.INTRODUCTION
Telomerase is a ribonucleoprotein (RNP) reverse transcriptase
(Gillis et al., 2008) responsible for replicating the ends of chromo-
somes and maintaining genome integrity. The tcTERT structure
consists of four distinct domains (TRBD, fingers, palm, and
thumb) organized into a ring configuration creating a large inte-
rior cavity for RNA template and telomeric DNA binding during
telomere elongation (Gillis et al., 2008; Mitchell et al., 2010).
The recent electronmicroscopy (EM) structure of human telome-
rase shows that the TERT ring can undergo significant rigid
conformational changes, allowing for an open and closed config-
uration possibly required for telomerase RNP assembly (Sauer-
wald et al., 2013). TERT closed-ring configuration is mediated
by extensive interactions between the TRBD and the thumb,
the two terminal domains of tcTERT (Gillis et al., 2008; Mitchell
et al., 2010). The vertebrate TRBD facilitates telomerase ribonu-
cleoprotein assembly via CR4/5 (Bley et al., 2011; Huang et al.,1934 Structure 23, 1934–1942, October 6, 2015 ª2015 Elsevier Ltd A2014) and template boundary element (Harkisheimer et al.,
2013; Rouda and Skordalakes, 2007) binding.
Strategies to inhibit telomerase generally target either TERT or
TER (Harley, 2008; Shay and Keith, 2008; Shay and Wright,
2002), although indirect inhibitors targeting telomerase sub-
strates and regulators are also used to a lesser extent, such
as G-quadruplex binders (Hurley et al., 2000; Neidle and Read,
2000). Direct inhibitors of telomerase catalytic activity include
both nucleoside and non-nucleoside inhibitors (Fletcher et al.,
1996, 2001; Gomez et al., 1998; Hajek et al., 2005; Liu et al.,
2007; Murakami et al., 1999; Strahl and Blackburn, 1994; Yama-
guchi et al., 2000, 2006; Yegorov et al., 1996, 1997). BIBR1532
(2-[(E)-3-naphtalen-2-yl-but-2-enoylamino]-benzoic acid) is a
non-nucleosidic, non-competitive, small-molecule inhibitor of
telomerase that is widely and routinely used in studies of telome-
rase function. BIBR1532 is a highly selective inhibitor of telome-
rase that has a direct antiproliferative effect on leukemia cells
but not on normal hematopoietic stem cells (Damm et al.,
2001; El-Daly et al., 2005; Pascolo et al., 2002). Despite exten-
sive use of BIBR1532 in biochemical, kinetic, and in vivo studies,
its precise mechanism of inhibition of telomerase remains
unclear.
The data presented here provide an atomic view of the interac-
tion of TERT with the small-molecule inhibitor BIBR1532. It iden-
tifies a novel motif (FVYL) on the thumb domain that can be
targeted to specifically inhibit telomerase function. It supports
the hypothesis that the thumb and TRBD domains of TERT
bind CR4/5, contacts that promote telomerase RNP assembly
and possibly stabilize the closed configuration of the TERT ring
required for full telomerase function.
RESULTS
BIBR1532 Binds to a Hydrophobic Pocket on the Outer
Surface of the Thumb Domain
Crystals of the tcTERT-BIBR1532 were prepared by soaking
the substrate-free tcTERT crystals with BIBR1532. tcTERT
crystals bound to BIBR1532 diffracted to significantly higher res-
olution (2.3 A˚, Table 1) than the substrate-free enzyme (2.7 A˚),
thus providing the atomic resolution required for detailed anal-
ysis of small-molecule binding to a protein. The structure was
solved by molecular replacement using the substrate-free
enzyme PDB: 3DU6. Structural comparisons of the substrate-
free and BIBR1532 bound tcTERT rings showed an overallll rights reserved
Table 1. Data Collection and Refinement Statistics
tcTERT-BIBR1532
Data Collection
Space group P21
Cell dimensions
a, b, c (A˚), b () 117.7, 84.9, 123.3, 116.2
Resolution (A˚) 20–2.3 (2.42–2.3)a
Rsym or Rmerge 12.3 (47.1)
I/sI 4.3 (1.5)
Completeness (%) 99.6 (98.9)
Redundancy 3.0 (2.9)
Refinement
Resolution (A˚) 20–2.3
No. of reflections 19,815
Rwork/Rfree 23.5/27.3
No. of atoms
Protein 9,964
Ligand/ion 50
Water 430
Mean B value 48
RMSDs
Bond lengths (A˚) 0.009
Bond angles () 0.1043
aValues in parentheses are for highest-resolution shell.root-mean-square deviation (RMSD) of 0.5 A˚, suggesting no
major conformational changes to the protein structure upon in-
hibitor binding.
Experimental and simulated annealing omit maps showed
clear, interpretable density for BIBR1532 (Figure 1A) at a shallow
but well-defined hydrophobic pocket located on the outer sur-
face of the thumb domain of telomerase and adjacent to the
TRBD-thumb interface (Figures 1C and 1D). This pocket is the
result of a small gap, approximately 10 A˚ wide and 8 A˚ deep,
formed by the organization of the tips and connecting loops of
helices a20, a21, and a22, a23 (Figures 1B and 1D). The gap
generated between these two sets of helices arises from an up-
ward rotation of helix a21 with respect to the a22 and a23 plane
by approximately 25 (Figure 1D). We refer to this pocket as the
FVYL motif/pocket, based on the conserved hydrophobic resi-
dues that form this motif: F478, V491, Y551, and L554 (Figures
2B and 2C). The FVYL residues are involved in extensive hydro-
phobic interactions that stabilize the orientation of the loops
and a helices surrounding the pocket. F478 is at the center of hy-
drophobic interactions between helices a20, a21 and a22, a23.
V491 pins back the loop connecting a20 and a21 via extensive
contacts with L485 and F496. Contacts of V491 with L485 and
F496 contribute to the shape of the pocket and keep it in an
open configuration. Y551, L445 of a22 interact with L501 of
a20 and F478 of a21, respectively, also contributing to the posi-
tioning of a22 and the shape of the FVYL pocket.
Several conserved and mostly hydrophobic residues line the
interior of this pocket, which include M482, M483, F494, I497,
W498, I550, Y551, and L554 (Figure 1B). Even though binding
of BIBR1532 in this location does not induce significant globalStructure 23, 1934–conformational changes to the TERT ring (RMSD between the
substrate-free and BIBR1532-bound structures is 0.5 A˚), the
loop that connects helices a20 and a21 and forms the upper
lip of this pocket is moved closer toward the bottom of the
pocket by 1 A˚, providing a tighter grip on the small hydrophobic
substrate.
The BIBR1532 naphthalene group is sandwiched by the hy-
drophobic side chain of L554, the backbone of G495, and part
of F494 (Figures 2C and 2D). Additional contacts between the
naphthalene group and the protein are mediated by the side
chains of W498 and I497, both of which are located at the
back end of the pocket. The methyl moiety of the butynoylamino
group points toward the back wall of the pocket and makes van
der Waals contacts with the side chains of M482 and Y551. The
side chains of F494 and I550 form a hydrophobic pincer that
sandwiches the benzoic group of BIBR1532. Additional contacts
with this group involve M483 and the aliphatic part of the side
chain of R486. The acid portion of the benzoic moiety of the in-
hibitor points toward the solvent-exposed part of the pocket
and does not make contact with the protein.
Conservation between the Human and Tribolium
castaneum BIBR1532 and TERT Binding Pockets
Wegenerated a sequence alignment that consists of tcTERT and
vertebrate telomerase sequences including hTERT to determine
whether the FVYL motif is conserved between tcTERT and
hTERT (Figure 2A). Sequence alignment shows striking similarity
in the amino acid composition of the two FVYL pockets. The
BIBR binding site residues F478, V491, Y551, and L554 of
tcTERT (corresponding to F1012, V1025, Y1089, and L1092 of
hTERT) are invariant among the two telomerases.We also exam-
ined the structural conservation of tcTERT and hTERT using the
hTERT model published by Steczkiewicz et al. (2011). Structural
alignment of the tcTERT and hTERT thumb domains shows that
the a20, a21, a22, and a23 helices occupy nearly identical posi-
tions to create a conserved and solvent-exposed hydrophobic
pocket (Figures 2B–2E). F1012 is located on helix a20, and is
at the center of a network of hydrophobic contacts with a21,
a22, and a23 (Figure 2C). Y1089 and L1092 make direct hydro-
phobic contacts with F1012 to stabilize the position of helix
a22. On the opposite side of the pocket, V1025 holds the loop
connecting a20 and a21 in place. Conservation of these key
structural elements between tcTERT and hTERT suggests that
the organization of the FVYL pocket is conserved across
species.
Mutants of the Telomerase FVYL Pocket Lead to
Telomere Attrition
We engineered a series of single hTERT mutants designed to
perturb the natural substrate binding properties of the FVYL
pocket to determine the role of the FVYL motif in telomerase
function. Some of these mutations were modeled after the natu-
rally occurring mutations N1028H and V1090M associated with
human disease.We also identified small solvent-exposed hTERT
residues in the FVYL pocket that could be converted into bulky
aromatic residues without disrupting the overall fold of the pro-
tein. These mutations include V1016F, N1028W, T1088F, and
T1088W (Figures 2A–2C). Modeling of the larger side chains
into the hTERT structure indicates that these mutant residues1942, October 6, 2015 ª2015 Elsevier Ltd All rights reserved 1935
Figure 1. Structure of the tcTERT-BIBR1532
Complex
(A) Molecular structure of BIBR1532.
(B) Simulated annealing omit map (blue mesh) of
BBR1532 (yellow stick) bound to the tcTERT thumb
domain; residues interacting with the inhibitor are
shown as sticks.
(C and D) BIBR1532 binds in proximity to the TRBD-
CR4/5 binding interface. (C) Surface representation of
tcTERT showing the active site in red, the thumb DNA
binding site in green, and the TRBD CR4/5 binding
site in magenta. BIBR1532 is shown as yellow
spheres. (D) Cartoon representation of tcTERT, de-
picting (C rotated 90)-BIBR1532 (yellow surface/
stick) complex.can adopt conformations that obstruct or enhance substrate
binding, but do not destabilize the hTERT structure.
We transfected human fibroblasts (CCD-1058Sk, ATCC) with
wild-type (WT) hTERT, mutant hTERT, or empty vector (mock
treated). All cell lines retained normal morphology; however,
fibroblasts transfected with WT or mutant hTERT continued
dividing even after senescence of the mock-treated cells.
This suggests the mutant proteins retained some level of prolif-
erative activity. Western blot analysis showed that the proteins
were expressed at similar levels, demonstrating that the mutant
proteins were correctly folded and, therefore, not degraded
(Figure 3A).
Southern blot analysis of DNA isolated from fibroblasts trans-
fected with WT hTERT shows robust telomere lengthening at
passages 18 and 23 (Figures 3B and 3C). In contrast, telomeric
DNA isolated from fibroblasts transformed with hTERT mutants
(V1016F, N1028W, T10180F, and T10180W) showed gradual
attrition (Figures 3B and 3C).
Occlusion of the FVYL Pocket of Telomerase Results in
Chromosomal Abnormalities Associated with Telomere
Shortening In Vivo
In an attempt to further establish the role of the FVYL motif in
telomerase function and telomere maintenance, we asked
whether the telomerase mutations V1016F, N1028W, and
T1080F lead to chromosomal abnormalities associated with
chromosome free ends and fusions. We assayed for defective
telomere phenotypes observable by fluorescence in situ hybrid-
ization (FISH) analysis, in human fibroblasts (CCD-1058Sk)
immortalized with WT and mutant (V1016F, N1028W, T10180F,
and T10180W) human telomerases. We prepared metaphase
spreads and counted the frequency of telomere fusions, fragile
telomeres, and telomere/signal free ends (TFE). We observed a
significantly increased proportion of TFE (Figures 4A–4C), and
a slight increase in fragile telomeres, in themutant cell lines. Cells
expressing WT telomerase showed 11% of chromosomes with
TFE, compared with 24% in V1016F, 28.0% in N28W, 23.5%
in T1088F, and 25% in T1088W (Figure 4C).1936 Structure 23, 1934–1942, October 6, 2015 ª2015 Elsevier Ltd All rights reservedTERT Mutants that Occlude the FVYL
Pocket Exhibit Reduced Telomerase
Activity
Next, we sought to establish whether the
FVYL pocket residues directly influence thecatalytic activity of telomerase. To this end we carried out telo-
meric repeat amplification protocol (TRAP) assays using cell ly-
sates of fibroblasts expressing either WT or one of the FVYL
mutant (V1016F, N1028W, T10180F, and T10180W) hTERT pro-
teins. Consistent with the southern blot and FISH data, the
V1016F and N1028W mutations showed significantly reduced
telomerase activity (>70%) compared with the WT enzyme (Fig-
ures 5A–5C). The T1088F and T1088W mutants showed 60%–
70% of WT TRAP activity, even though these mutants do not
support robust WT telomere extension in fibroblast cells (Figures
5A–5C).
The BIBR1532 Binding Pocket of TERT Binds hTER
The structural data presented here show that the FVYL motif is
located in proximity (12 A˚) to the CR4/5 binding interface of
TRBD (Figure 1C). The proximity of the BRIBR1532 binding
pocket of TERT to the TRBD-CR4/5 binding interface suggested
that the thumb domainmay also bemaking contact with the acti-
vation domain of CR4/5 and, in particular, the P6.1 stem loop
(Figure 6A). We expressed and purified the WT and mutant
(T1088F, N1028H, and V1090M) hThumb proteins to homogene-
ity to test this hypothesis (Figure 6B). We tested these proteins
for CR4/5 binding using fluorescence polarization (FP) assays
in the presence of 30-fold excess of cold tRNA competitor and
competition assays (Figures 6D and 6E). The WT hThumb
domain has a Kd of 0.4 mM for the CR4/5, while the mutant
hThumb proteins displayed an overall 2- to 5-fold change in
CR4/5 binding (Figure 6C). We performed FP assays of WT
hThumb with CR4/5 lacking the P6.1 stem loop to determine
whether P6.1 contributes to hThumb binding. The WT hThumb
domain showed a 2.5-fold loss of binding affinity for CR4/5minus
P6.1, suggesting that P6.1 plays an important role in TERT-TER
association.
DISCUSSION
Treatment of cancer cells with BIBR1532 leads to progressive
telomere shortening, cell proliferation arrest after several weeks
Figure 2. Structural Comparison of the
tcTERT and hTERT FVYL Pockets
(A) Sequence alignment (Clustal W2) highlighting
(purple) the residues of tcTERT and hTERT
involved in BIBR1532 binding. Residues mutated
in this study are indicated by a black arrowhead.
Naturally occurring missense mutations implicated
in human disease are indicated by a red arrowhead
(Larkin et al., 2007; Goujon et al., 2010).
(B and C) Structural comparison of the tcTERT
(crystal structure) (B) and hTERT (PNAS model) (C)
FVYL pockets in complex with BIBR1532 (yellow
stick); residues involved in inhibitor binding are
shown as sticks. Black boxes indicate hTERT
residues mutated in cell-based and RNA binding
assays. Residues associated with human disease
are shown in red boxes.
(D and E) Electrostatic surface representation of
tcTERT (D) and hTERT (E) showing BIBR1532
bound to the FVYL pocket for comparison.of drug treatment, and senescence. Understanding the mecha-
nism of telomerase inhibition by small-molecule inhibitors such
as BIBR1532 on an atomic level will assist in our effort to identify
and develop useful telomerase inhibitors as potential therapeu-
tics for cancer.
Our structural data show that BIBR1532 binds to a well-
defined hydrophobic pocket on the outer surface of the thumbStructure 23, 1934–1942, October 6, 2015domain. The key residues in structural
organization of the FVYL motif are
conserved across species, and the
pocket is solvent-accessible for substrate
binding (Figures 1D, 2D, and 2E).
Although this report is the first structural
and biochemical characterization of the
FVYL pocket, mutations to FVYL residues
have previously been implicated in human
disease. The hTERT FVYL mutationsV1025F, N1028H, and V1090M (Figures 2A and 2C) are associ-
ated with bone marrow syndrome failure and severe aplastic
anemia (Garcia et al., 2007; Yamaguchi et al., 2005). V1025 is a
conserved residue of the FVYL motif and plays a critical role in
stabilizing the open conformation of the BIBR1532 binding
pocket. N1028 forms part of the loop that connects a20 and
a21, and the aliphatic part of its side chain makes contact withFigure 3. Southern Blot Analysis of CCD-
1058Sk Infected Cells with Wild-Type and
FVYL Mutant hTERTs
(A) Western blot showing expression levels of wild-
type (WT) and mutant hTERT proteins in CCD-
1058Sk cells.
(B) Southern blot analysis of FVYL pocket WT and
mutant telomerases showing clear loss of telomere
length with time (passages 1, 13, and 28).
(C) Bar-graph analysis of the telomere length for
each cell line at passages 1, 13, and 28 (TeloTool;
MATLAB) (Gohring et al., 2014). The SD (error bars)
associated with measurements and the statistical
significance of the data are shown. *p < 0.01 (two-
tailed paired Student’s t test).
ª2015 Elsevier Ltd All rights reserved 1937
Figure 4. Fluorescence In Situ Hybridization Data of CCD-1058Sk
Infected Cells with Wild-Type and FVYL Mutant hTERTs
(A and B) Fluorescence in situ hybridization (FISH) data at passage 21 showing
chromosomes of CCD-1058Sk cells transformed with (A) WT hTERT and (B)
FVYL pocket mutant hTERT; chromosomes with free telomere ends are indi-
cated by an orange arrow.
(C) Percentage of telomere/signal free ends in WT and FVYL mutant hTERT
transfected CCD-1058Sk cells. The SD (error bars) associated with an average
of 1,500 chromosomemeasurements for each cell line carrying theWT or each
of the FVYL pocket mutant hTERTs and the statistical significance of the data
are shown. *p < 0.05 (two-tailed paired Student’s t test).the butynoylamino group of BIBR1532. V1090 forms part of a
solvent-accessible loop that connects helices a22 and a23 and
is not involved in direct contact with the rest of the protein. A pre-
vious study demonstrated that the V1090M mutation leads to a
dramatic loss of telomerase activity (Yamaguchi et al., 2005),
which is consistent with our data.
Our cell-based assays clearly show that the FYVL pocket mu-
tations V1016F, N1028W, T1088F, and T1088W lead to telomere
shortening (Figures 3B and 3C), telomere free ends (Figures 4A–
4C), and loss of telomerase activity (Figures 5B and 5C). V1016
occupies a rigid position on helix a20 and occupies part of the
back wall of the FYVL pocket (Figure 2C). The large hydrophobic
side chain of the V1016Fmutation most likely occludes the FVYL
pocket, thus affecting substrate binding and telomerase activity.
N1028 forms part of helix a21 and is located at the center of the
entry of the FYVL pocket; therefore, the N1028W mutation also
disrupts substrate binding and enzymatic activity (Figure 2C).
In contrast, T1088 is part of the loop that links helices a22 and
a23; therefore, this coil is likely more flexible compared with1938 Structure 23, 1934–1942, October 6, 2015 ª2015 Elsevier Ltd Athe helical residues V1016 and N1028 (Figure 2C). Thus, the
aromatic residues introduced by the T1088F and T1088Wmuta-
tions may move aside to accommodate substrate binding, re-
sulting in limited loss of activity of these mutants.
Notably, although FVYL mutations reduce hTERT activity and
prevent telomere extension, the FVYLmutant hTERT still allowed
fibroblasts to bypass their normal senescence point. These data
are in agreement with previous studies on BIBR1532, which
show that it takes approximately 120 days for BIBR1532-treated
leukemia cells to enter senescence (Damm et al., 2001; El-Daly
et al., 2005; Pascolo et al., 2002). The lag time to reaching senes-
cence suggests that telomerase retains some pro-proliferative
activity and that cancer cells only reach senescence after exten-
sive telomere attrition. FVYL mutations show effects similar to
BIBR1532 treatment on both cell proliferation and hTERT activ-
ity, further supporting the role of the FVYL pocket in BIBR1532
binding.
Core functions of the thumb domain of telomerase involve sin-
gle-stranded nucleic acid binding (Hossain et al., 2002; Mitchell
et al., 2010), elongation complex formation, and polymerase ac-
tivity (Banik et al., 2002; Hossain et al., 2002; Huard et al., 2003;
Mitchell et al., 2010; Peng et al., 2001), characteristics shared
among reverse transcriptases and DNA polymerases. In the
case of telomerase, DNA binding is mediated by the conserved
thumb helix and loopmotifs, both of which face the interior cavity
of the TERT ring (Gillis et al., 2008; Mitchell et al., 2010). Because
of the critical role that the thumb domain plays in DNA binding,
we considered the possibility that BIBR1532 binding disrupts
the DNA binding pocket. However, the FVYL pocket is located
at least 25 A˚ away from the thumb helix and loop motifs (Fig-
ure 1C). Moreover, inhibitor binding to the FYVL pocket does
not induce conformational changes that would affect DNA bind-
ing by this domain (RMSD = 0.5).
Interestingly, the FVYL pocket is located adjacent to the
thumb-TRBD binding interface (Gillis et al., 2008; Mitchell
et al., 2010) and in proximity to the CR4/5 RNA binding surface
of TRBD (Bley et al., 2011; Huang et al., 2014) (Figure 1C), which
led us to investigate binding between FVYL and the CR4/5. The
results of our FP binding assays show that mutations to
the hTERT FVYL motif exert a strong influence on binding to
the CR4/5 element of hTER. For example, the T1088F hThumb
mutant binds the CR4/5 with 5-fold higher affinity than WT
hThumb, suggesting that a large aromatic residue in the FVYL
motif is positioned to make favorable interactions with substrate
RNA. Similarly, the N1028H mutant binds the RNA with approx-
imately 2-fold higher affinity, also suggesting favorable interac-
tions between the RNA substrate and the larger pyrimidine-like
side chain of histidine. In contrast, the V1090M mutant has a
reduced affinity for the RNA substrate, suggesting interference
with the association of hTERT with CR4/5. It is interesting that
the these mutations (N1028H, T1088F, and V1090M) have oppo-
site effects in RNA binding, yet they all reduce telomerase
activity (Yamaguchi et al., 2005). Telomerase activity is tightly
regulated so that proper length of telomeres is maintained.
Telomere length regulation is directly dependent on the proper
assembly of the telomerase RNP complex. Subtle changes in
the residue composition of TERT or TER can affect proper telo-
merase RNP assembly and telomerase activity, leading to cell
immortalization or senescence.ll rights reserved
Figure 5. Telomerase Activity Assays of
CCD-1058Sk Infected Cells with Wild-Type
and FVYL Mutant hTERTs
(A) TRAP activity of WT telomerase in 0, 0.25, 0.5,
0.75, and 1 mg total lysate protein concentration.
(B) TRAP gel showing the activity ofWT telomerase
alongside the mutants N1028W, V1016F, T1088F,
and T1088W in 0.5 mg of total lysate protein.
(C) Bar graph showing the relative activity, in terms
of band intensity, of the WT and FVYL mutant te-
lomerases. The SD (error bars) associated with
three measurements and the statistical signifi-
cance of the data are shown. *p < 0.005 (two-tailed
paired Student’s t test).Usinganoverlayof tcTERTand thestructure of theTRDB-CR4/
5 complex we identified the stem loop P6.1 of CR4/5 as a poten-
tial candidate for hThumb binding. The RNA binding assays pre-
sented here show that WT hThumb binds CR4/5 with 2-fold
higher affinity than the CR4/5 P6.1 (Figures 6C–6E). An overlay
of the tcTERT crystal structure with the olTRBD-CR4/5 (RMSD
between tcTRBD and olTRBD is 2.6 A˚, which is within the range
observed for telomerase TRBDs across species; e.g., 2.3 A˚ for
olTRBD or trTRBD and Tetrahymena thermophila TRBD) places
the P6.1 loop region within coordinating distance of the FVYL
pocket (Figure 7). The data presented here and the physical prox-
imity of the FVYL pocket to the CR4/5 binding surface of TRBD
suggest that P6.1 is the natural substrate of the FVYL pocket.
Contacts between the FVYL pocket and CR4/5 most likely
promote telomerase RNP assembly and enzymatic activity.
Another possibility is that CR4/5 binding between FVYL and
the CR4/5 stabilizes the closed TERT ring configuration, also
contributing to the enzymatic activity of telomerase. The EM
structure of human telomerase shows that the TERT ring can
adopt open and closed conformations (Sauerwald et al., 2013).
It is possible that contacts between the CR4/5 and the thumb
and TRBD domains stabilize the closed configuration of the
TERT ring, thus promoting function. Binding of BIB1532 to the
FVYL motif disrupts CR4/5 thumb binding and prevents proper
telomerase RNP assembly.EXPERIMENTAL PROCEDURES
Protein Crystallization and Data Collection
The tcTERT protein was expressed and purified as described previously (Gillis
et al., 2008; Mitchell et al., 2010). The purified tcTERT was concentrated to
40 mg/ml and dialyzed in 10 mM Tris-HCl (pH 7.5), 0.1 M KCl, and 1 mM
TCEP prior to crystallographic studies. tcTERT was co-crystallized with sin-
gle-stranded DNA consisting of three telomeric repeats (TCAGG)3 at 18
CStructure 23, 1934–1942, October 6, 2015by sitting-drop vapor diffusion. The crystallization
buffer contained 1.3 M NaNO3 and 0.1 M Tris-
HCl (pH 8.5). The fully formed crystals were stabi-
lized in a solution containing 1.3 M NaNO3, 0.1 M
Tris-HCl (pH 8.5), and 30% glycerol overnight. To
these crystals were then added trace amounts of
BIBR1532 powder, and the two were incubated
for 10 hr prior to harvesting. The inhibitor-soaked
tcTERT crystals were flash-frozen in liquid N2,
and data were collected at the NSLS X25 beamline
and processed using MOSFLM as implemented in
Elves (Holton and Alber, 2004). The model wasrefined using REFMAC5 (Murshudov et al., 1997). Figures were prepared in
PyMOL (http://www.pymol.org).
Cell Culture
Human cell culture studies were carried out in CCD-1058Sk cells, grown in
DMEM (Gibco) and 10% fetal bovine serum (Gibco). WT and mutant hTERT
genes in the pLU-EF1a-iBLAST vector, which confers blasticidin S resistance,
were delivered by infection with lentiviral vectors. Infected cell lines were
grown in the presence of 5 mg/ml blasticidin S to ensure that they continued
plasmid expression. Cells were trypsinized and counted, and 1 3 106 cells
were replated three times per week.
Western Blot Analysis
We isolated approximately 3 3 106 CCD-1058Sk cells of the WT and each
mutant telomerase by centrifugation. We lysed the cells in 300 ml of pre-chilled
RIPA buffer (50 mM Tris-HCl [pH 7.5], 150 mM NaCl, 0.1% SDS, 0.5% sodium
deoxycholate, 1% Triton X-100). Lysates were centrifuged for 15 min at
20,000 3 g and the supernatant saved. We quantified the lysate protein con-
centration using a Bradford assay (Bradford, 1976), and 25 mg of each sample
was run on a polyacrylamide gel. We then blotted the protein onto a polyviny-
lidene fluoride membrane (PerkinElmer) by electrophoretic blot at 200 mA for
3 hr at 4 C in 20%methanol, 125mMTris-HCl, 1.25M glycine, and 0.5%SDS.
We blocked the membrane with TBST (100 mM Tris-HCl [pH 7.5], 2 M NaCl,
0.5% Tween 20) and 5% BSA, washed with TBST, and then incubated over-
night with monoclonal anti-FLAG antibody M2 produced in mouse (Sigma) in
TBST at 4C. We further washed the membrane with TBST, incubated with
TERT antibody (H-231) sc-7212 (Santa Cruz Biotechnology) for 2 hr, and
washed again with TBST. The chemiluminescent horseradish peroxidase re-
action was activated using SuperSignal West Pico Substrate (Thermo Scienti-
fic), and the image developed with CL-exposure film (Thermo Scientific).
Southern Blot Analysis of hTERT Transfected Fibroblasts,
CCD-1058sSk
Genomic DNA was extracted from the WT and FVYL mutant hTERT trans-
fected fibroblasts using a QIAamp DNA-mini Kit (Qiagen). 10 mg of genomic
DNA from each sample was digested overnight at 37C using 20 U of MboI
(NEB) and 20 U of AluI (Invitrogen). Digested DNA was precipitated in
10 mM NaOAc, 1 mM MgCl2, and 75% ethanol overnight at 20C, thenª2015 Elsevier Ltd All rights reserved 1939
Figure 6. Human Thumb Domain-RNA Bind-
ing Data
(A) Schematic of the hTER RNA showing
conserved motifs in color. The CR4/5 and P6.1
motifs are highlighted with a blue dashed box. The
template, pseudoknot, and other conserved re-
gions are also shown faded.
(B) SDS-PAGE gel of the WT and mutant hThumb
proteins used in this study.
(C) Table of WT and mutant hThumb-template
boundary element binding constants calculated
using Prism5 (GraphPad).
(D) FP data of the CR4/5 with WT, N1028H,
T1088F, and V1090M hThumb proteins.
(E) FP data of the CR4/5 minus P6.1 stem loop with
WT hThumb. Error bars for (D) and (E) were each
calculated from three independent measurements.
(F) EMSA gel of the competition assay of hThumb-
CR4/5 complex with cold CR4/5.pelleted and resuspended in DNase-free water. 3 mg of each sample was run
on a 0.5% agarose gel in 13 Tris-acetate EDTA buffer for 4.5 hr at 120 V. The
gel was sequentially washed with 0.25 M HCl, denaturing buffer (0.5 M NaOH,
1.5 M NaCl), and neutralization buffer (0.5 M Tris-HCl, 3 M NaCl [pH 7.5]), then
blotted onto hybridization transfer membrane (Genescreen Plus; PerkinElmer).
DNA was cross-linked to the membrane using a UV Stratalinker 1800 (Strata-
gene), and hybridized with 0.2 nM 32P labeled DNA probe (TTAGGG)4 over-
night at 42C in 25 ml of church buffer (7% SDS, 0.25 M Na2PO4 [pH 7.2],
1 mM EDTA, 1% w/v BSA). The membrane was washed with 20 mM
Na2PO4 (pH 7.2), 1% (w/v) SDS, and 1 mM EDTA, exposed to a phosphor
imager, and the image developed on a typhoon scanner (GE Healthcare).
The telomere length was calculated using the software TeloTool (MATLAB)
(Gohring et al., 2014).
Fluorescence In Situ Hybridization
We treated fibroblast cells transfected with WT and mutant telomerase with
100 mg/ml colcemid for 7 hr. The cells were grown to 70% confluence after
21 passages on a 10-cm plate. Cells were then trypsinized to detach them
from the plate, pelleted, and treated in a hypertonic environment (75 mM
KCl for 30 min at 37C) to rupture them.We fixed the cells in 10 ml of 3:1 meth-
anol/acetic acid solution and stored them at 4C. Metaphase spreads were
fixed in 4% formaldehyde (Sigma), treated with 1 mg/ml pepsin in 10 mM
glycine (pH 2.0) at 37C (Sigma), and fixed again with 4% formaldehyde. The
slides were then dehydrated with ethanol, air-dried, and hybridized with
20 ml of 200 nM telomeric-Cy5 peptide nucleic acid probe (TelC-Cy5 PNA;
LI-COR Biosciences) according to the manufacturer’s instructions. Slides
were counterstained with DAPI and imaged using a Nikon E600 upright
microscope.
Telomerase Repeat Amplification Protocol Assay
Total cell lysates were prepared using CHAPS lysis buffer (10 mM Tris-HCl,
1 mM MgCl2, 1 mM EGTA, 0.1 mM benzamidine, 1 mM PMSF, 5 mM b-mer-
captoethanol, 0.5% CHAPS, 10% glycerol). WT telomerase lysates contain-
ing 0 (no lysate), 0.25, 0.5, 0.75, and 1 mg of total protein were incubated in
a TRAP extension buffer (20 mM Tris-HCl [pH 8.3], 63 mM KCl, 1.5 mM
MgCl2, 1 mM EGTA, 0.005% Tween 20, 0.1 mg BSA, 32 U RNasin, 1 mM TS
primer [50-AATCCGTCGAGCAGAGTT-30], 0.1 mM dinucleotide triphosphates
[NTPs], 0.1mMDTT, 0.1mMPMSF, and 0.1mMbenzamidine) for 1 hr at 37C,
then 10 nmol of a 32P-labeled loading control (single-stranded, yeast telomeric
DNA, 26 bases long) was added to each sample. DNA was isolated by phenyl-
chloroform extraction, and precipitated in 10 mM NaOAc, 1 mM MgCl2, and
75% ethanol overnight at 20C, then pelleted and resuspended in DNase-
free water. The DNA samples were resuspended and PCR-amplified in 50 ml
of TRAP PCR buffer (13 CoralLoad buffer, 0.2 mM dNTPs, 2 mM CX primer1940 Structure 23, 1934–1942, October 6, 2015 ª2015 Elsevier Ltd A[50-CCCTTACCCTTACCCTTACCCTAA-30] containing 1.25 U of Taq DNA
polymerase [Qiagen]). We then added 10 ml of formamide loading buffer
(95% formamide, 4.5% dH2O, 0.25% bromophenol blue, and 0.25% xylene
cyanol) to each sample and incubated it at 95C for 10 min. Samples were
run on a 10% polyacrylamide, 7 M urea (19:1) gel for 2 hr at 70 W. The gel
was fixed with 20% ethanol and 5% acetic acid, vacuum-dried, and imaged
as described above. We subsequently used the above procedure to perform
a TRAP assay for the WT and the mutant telomerases at 0.5 mg of total lysate
protein. Telomerase activity and SDwere calculated from threemeasurements
each. ImageJ was used to determine band intensities on the gel, and the three
measurements for each band were averaged and the SD calculated for each
repeat. The band-intensity averages and SDs were then normalized to the in-
tensity of the loading control. Finally, the WT mean average was set to 100%
activity, and the mutant averages were calculated as a percentage of this.
Human Thumb Domain Protein Expression and Purification
The human thumb (hThumb, CTE) domain, consisting of residues 943–1132,
was cloned into a modified vector expressing a hexahistidine tag (His-tag) fol-
lowed by a tobacco etch virus (TEV)-cleavable small ubiquitin-like modifier
(SUMO) fusion protein at its N terminus. The protein was overexpressed in
E. coli ScarabXpress-1 (T7Lac) cells (Scarab Genomics) at 16C overnight us-
ing 1 mM IPTG (isopropyl-b-D-thiogalactopyranoside; Gold Biotechnology).
Cells were harvested by centrifugation and resuspended in a buffer containing
95%: 1 M KCl, 25 mM Tris-HCl, 5% glycerol, 0.1 mM benzamidine, 0.1 M
PMSF (pH 7.5); and 5%: 0.5 M KCl, 25 mM Tris-HCl, 300 mM imidazole, 5%
glycerol, 0.1 mM benzamidine, 0.1 M PMSF (pH 7.5) prior to lysis via
sonication. The hThumb protein was then purified over an Ni-nitrilotriacetic
acid resin (Ni.NTA; MCLab) column. The His-SUMO-tag was cleaved by TEV
endopeptidase overnight at 4C. We further purified the protein over a porous
HS resin (Applied Biosystems) column using a gradient of 25 mM Tris-HCl,
0.5–1.5 M KCl, 5% glycerol, and 1 mM DTT (pH 7.5). The mutant constructs
V1090M, N1028H, and T1088F were overexpressed and purified using the
same procedure used for the WT protein.
Fluorescence Polarization Assays
We performed FP hThumb-CR4/5 (CCC GCC TGG AGG CCG CGG TCC GCC
GCG AAG AGT TGG GCT CTG TCA GCC GCG GG) and CR4/5 minus P6.1
binding reactions in 15 ml samples using an Envision Xcite Multilabel Plate
Reader (PerkinElmer). The binding reactions were carried out in a buffer con-
taining 20mM Tris-HCl [pH 7.5], 100mMKCl, 2 mMMgCl2, 1 mMEDTA, 2mM
DTT, 1 mg/ml BSA, 5% (v/v) glycerol, and 75 nM cold tRNA competitor
(Ambion yeast tRNA; Life Technologies). The RNA probes were purchased
with a 50 6-FAM label from IDT and Dharmacon. The final probe concentration
used was 2.5 nM, while the hThumb protein concentration ranged from 0 toll rights reserved
Figure 7. Model of TERT, CR4/5 Binding
Overlay of the crystal structures of tcTERT (PDB: 3DU6) and olTRBD-CR4/5
(PDB: 4026). tcTERT is shown in blue, olTRBD in yellow, and CR4/5 in cyan.
The P6.1 stem loop of CR4/5 interacting with the FVYL pocket is shown in red.5 mM. The reactions were incubated at room temperature for 5 min and pipet-
ted in triplicate into a black 384-well Optiplate (PerkinElmer). The reactions
were excited with 480 nm light and the emissions were measured at 535 nm
light. The millipolarization values were calculated by the Envision operating
software (PerkinElmer). The data were fit and the binding constants were
determined with a one-site binding, non-linear regression model using PRISM
5.0 (GraphPad, www.graphpad.com).
RNA Competition Assays
The CR4/5 RNA substrate was purchased from Dharmacon and labeled using
T4 polynucleotide kinase (New England Biolabs) and [g-32P]ATP, then purified
through a G25 column. Increasing concentrations of the WT hThumb protein
were incubated with 1 nM of the 32P-labeled CR4/5 on ice for 30 min and in
a buffer containing 20 mM Tris-HCl (pH 7.5), 150 mM NaCl, 2 mM DTT,
1 mM MgCl2, 5% glycerol, 1 mM EDTA, 30 nM cold tRNA (Ambion yeast
tRNA; Life Technologies) competitor, and 0.01% Triton X-100 for 30 min. For
the competition assay, increasing concentrations of unlabeled CR4/5 were
added to the reactions containing 250 nM hThumb protein. hThumb concen-
trations were calculated using a standard Bradford assay. The reactions were
then loaded onto 6%DNA retardation PAGE gels and run at 100 V for 1 hr. The
gels were fixed in 20%methanol/10% acetic acid and then vacuum-dried and
exposed using a storage phosphor screen (GE Healthcare).
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